Drug Type Small molecule drug |
Synonyms PPP, AXL-1717, NSC-36407 |
Target |
Mechanism IGF-1R antagonists(Insulin-like growth factor I receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC22H22O8 |
InChIKeyYJGVMLPVUAXIQN-HAEOHBJNSA-N |
CAS Registry477-47-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ependymoma | Phase 2 | US | 01 Dec 2012 | |
Glioblastoma | Phase 2 | US | 01 Dec 2012 | |
Gliosarcoma | Phase 2 | US | 01 Dec 2012 | |
Oligodendroglioma | Phase 2 | US | 01 Dec 2012 | |
Recurrent Malignant Glioma | Phase 2 | US | 01 Dec 2012 | |
WHO Grade III Mixed Glioma | Phase 2 | US | 01 Dec 2012 | |
Adenocarcinoma of Lung | Phase 2 | BY | 01 Dec 2011 | |
Adenocarcinoma of Lung | Phase 2 | HU | 01 Dec 2011 | |
Adenocarcinoma of Lung | Phase 2 | PL | 01 Dec 2011 | |
Adenocarcinoma of Lung | Phase 2 | RU | 01 Dec 2011 |
NCT01721577 (Pubmed) Manual | Phase 1 | 9 | byfchivomh(kicekxvrre) = Neutropenia, which was easily detected and reversible in all but one patient wkxlrmtahh (vsvrqknoxn ) | Positive | 06 Sep 2017 | ||
Phase 1 | 55 | didlxhqwhr(ogdjrbljqh) = 390 mg BID for four weeks aiqfnjpfbh (mvvdiqmkkf ) View more | Positive | 01 Jan 2016 | |||
Not Applicable | 515 | isyoelhtsx(pnmrpoeqsn) = lyunkgapxa sdgidrlxsq (xatytuothu, xxzbzfrgki - ffhzcmppcr) View more | - | 22 May 2015 | |||
PRP (Control) | isyoelhtsx(pnmrpoeqsn) = sauxiwrtec sdgidrlxsq (xatytuothu, vhvbjgxhrb - zqtrewqsgm) View more | ||||||
Phase 1 | Non-Small Cell Lung Cancer First line | 12 | tdyjjcslkl(cblnqdmbfs) = 215 mg BID AXL1717 cvngwrybaj (bvwyuumuhp ) View more | Positive | 01 Apr 2015 | ||
Phase 2 | 101 | rzhnwzsetm(zjnylvvmsf) = pphxvqqyly vreukmghgx (tapfwwvizb ) View more | - | 20 May 2014 | |||
rzhnwzsetm(zjnylvvmsf) = kvjohcfwfa vreukmghgx (tapfwwvizb ) View more |